Nuvig Therapeutics (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- December 06, 2024
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $161,000,000
Company Info
- Company Description
- Nuvig Therapeutics is a privately held biotechnology company developing novel immunomodulatory therapeutics for patients with inflammatory autoimmune diseases.
- Market
- Immunomodulatory therapeutics for inflammatory autoimmune diseases
- Location
- Menlo Park, California, USA
- Coinvestors
- Sanofi Ventures, Blue Owl Healthcare Opportunities, Norwest Venture Partners, B Capital, Leaps by Bayer, Global BioAccess Fund, LOTTE Holdings, Alexandria Venture Investments, abrdn Inc., Novo Holdings A/S, Platanus, Bristol Myers Squibb, Digitalis Ventures, Mission BioCapital